Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Florbetapir F 18 reader training evaluation
NCT02051790Phase 4Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Mar 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind, single-arm trial of Florbetapir in Alzheimer's disease (AD), sponsored by Avid Radiopharmaceuticals. Primary endpoint: Agreement Between Expert Panel and Clinical Practice Reads. Started Mar 2014; status: completed.
02
Drugs
Florbetapir
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02051790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02051790.